PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for MRK (Merck & Co Inc) from 1990 to Oct 24 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Merck & stock (MRK) PE ratio as of Oct 24 2021 is 37.05. More Details

Merck & PE Ratio (TTM) Chart

EMBED

Merck & PE Ratio (TTM) Historical Data

Total 1220
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Merck & PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2021-10-2437.1 2021-08-2335.8
2021-10-2237.1 2021-08-2035.9
2021-10-2137.1 2021-08-1935.8
2021-10-2037.0 2021-08-1835.5
2021-10-1936.3 2021-08-1736.0
2021-10-1835.2 2021-08-1635.6
2021-10-1535.8 2021-08-1335.0
2021-10-1435.8 2021-08-1234.7
2021-10-1336.1 2021-08-1134.3
2021-10-1236.3 2021-08-1034.3
2021-10-1136.5 2021-08-0934.4
2021-10-0836.8 2021-08-0634.5
2021-10-0737.4 2021-08-0534.5
2021-10-0636.8 2021-08-0434.5
2021-10-0537.3 2021-08-0334.9
2021-10-0438.0 2021-08-0234.8
2021-10-0137.2 2021-07-3035.1
2021-09-3034.3 2021-07-2935.1
2021-09-2934.3 2021-07-2835.8
2021-09-2833.5 2021-07-2735.6
2021-09-2733.5 2021-07-2635.3
2021-09-2433.6 2021-07-2335.4
2021-09-2333.4 2021-07-2235.0
2021-09-2232.9 2021-07-2134.9
2021-09-2132.9 2021-07-2034.8
2021-09-2032.8 2021-07-1935.2
2021-09-1732.7 2021-07-1635.6
2021-09-1632.9 2021-07-1535.6
2021-09-1533.3 2021-07-1435.4
2021-09-1432.9 2021-07-1335.4
2021-09-1333.4 2021-07-1235.4
2021-09-1033.5 2021-07-0935.6
2021-09-0933.7 2021-07-0835.7
2021-09-0834.4 2021-07-0735.9
2021-09-0734.7 2021-07-0635.7
2021-09-0635.3 2021-07-0535.9
2021-09-0335.3 2021-07-0235.9
2021-09-0235.2 2021-07-0135.6
2021-09-0134.8 2021-06-3035.5
2021-08-3134.8 2021-06-2935.3
2021-08-3034.9 2021-06-2835.1
2021-08-2734.8 2021-06-2528.0
2021-08-2635.0 2021-06-2427.7
2021-08-2535.2 2021-06-2327.4
2021-08-2435.5 2021-06-2227.6

Merck & PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Merck & Co Inc logo

Business Description

Industry
Healthcare » Drug Manufacturers » NAICS : 325412 SIC : 2834
Address
2000 Galloping Hill Road, Kenilworth, NJ, USA, 07033
Website
https://www.merck.com
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States.